# Winship Cancer Institute of Emory University

Source: https://onco.cc/institutions/emory-winship/  
OnCo record `emory-winship` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Winship is Georgia's only NCI comprehensive cancer centre; its myeloma programme under Sagar Lonial shaped daratumumab development, Suresh Ramalingam led the FLAURA trial that made osimertinib first-line for EGFR-mutant lung cancer, and it runs one of the South's largest phase 1 units.

## Summary

Founded in 1937 and NCI-designated in 2009, Winship achieved comprehensive status in 2017 and is Georgia's only NCI comprehensive centre. Sagar Lonial's myeloma programme has been central to daratumumab and other anti-CD38 and immunomodulatory drug development; Suresh Ramalingam led the FLAURA trial that made osimertinib the first-line standard in EGFR-mutant lung cancer. Kevin Kalinsky led RxPONDER, which defined which node-positive, HR-positive breast cancer patients benefit from chemotherapy. Winship opened a dedicated cancer tower at Emory Midtown in 2023 and runs one of the South's largest phase 1 units.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- City: Atlanta, GA, US
- Type: cancer-center
- NCI designation: comprehensive
- Website: https://winshipcancer.emory.edu

## Sources

- Winship Cancer Institute: https://winshipcancer.emory.edu
- Clinical trials: https://winshipcancer.emory.edu/clinical-trials/
- PTCOG: particle therapy facilities in operation: https://www.ptcog.site/index.php/facilities-in-operation-public

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Proton therapy machines: cyclotrons, synchrotrons and single-room systems](https://onco.cc/technologies/proton-therapy-systems/)
- targets: [CD38](https://onco.cc/targets/cd38/), [EGFR](https://onco.cc/targets/egfr/)
- drugs: [Daratumumab](https://onco.cc/drugs/daratumumab/), [Oncotype DX](https://onco.cc/drugs/oncotype-dx/), [Osimertinib](https://onco.cc/drugs/osimertinib/)
- companies: [NRG Oncology](https://onco.cc/companies/nrg-oncology/), [SWOG Cancer Research Network](https://onco.cc/companies/swog/)
- trials: [RxPONDER (SWOG S1007)](https://onco.cc/trials/rxponder/)
- people: [Deborah Watkins Bruner](https://onco.cc/people/deborah-bruner/), [Kevin Kalinsky](https://onco.cc/people/kevin-kalinsky/), [Robert W. Woodruff](https://onco.cc/people/robert-woodruff/), [Sagar Lonial](https://onco.cc/people/sagar-lonial/), [Suresh S. Ramalingam](https://onco.cc/people/suresh-ramalingam/)
- institutions: [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)

---
JSON: https://onco.cc/api/v1/entities/emory-winship.json